ADVANCEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as a big innovation in the sector of biopharmaceuticals, giving promising developments across numerous health care and industrial apps. With its structural similarity to naturally derived human serum albumin, OsrHSA provides a safer, much more reliable different for therapeutic use, significantly